β-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses

Human Gene Therapy

Volumn 9, Issue 12, 1998, Pages 1769-1774

  Puumalainen, Anu Maaria ^a,b   Vapalahti, Matti ^a,b   Agrawal, Reitu S ^a,c   Kossila, Maija ^a   Laukkanen, Johanna ^a   Lehtolainen, Pauliina ^a   Viita, Helena ^a   Paljärvi, Leo ^a   Vanninen, Ritva ^a   Ylä Herttuala, Seppo ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; VIRUS ANTIBODY; VIRUS VECTOR;

ADENOVIRUS; ADULT; AGED; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; GENE TRANSFER; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MARKER GENE; RETROVIRUS;

EID: 17344371681     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.12-1769     Document Type: Article

References (12)

1. AMMIRATI, M., GALICICH, J.H., ARBIT, E., and LIAO, Y. (1987). Reoperation in the treatment of recurrent intracranial malignant gliomas. Neurosurgery 21, 607-614.
2. AUSUBEL, P.M., BRENT, R., KINGSTON, R.E., MOORE, D.D., SEIDMAN, J.G., SMITH, J.A., and STRUHL, K., eds. (1991). Current Protocols in Molecular Biology. (Greene Publishing Associates and John Wiley & Sons, New York) pp. 4.2.3-4.2.4.
3. BARR, E., CARROLL, J., KALYNYCH, A.M., TRIPATHY, S.K., KOZARSKY, K., WILSON, J.M., and LEIDEN, J.M. (1994). Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Ther. 1, 51-58.
4. BI, W.L., PARYSEK, L.M., WARNICK, R., and STAMBROOK, P.J. (1993). In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum. Gene Ther. 4, 725-731.
5. BOVIATSIS, E., CHASE, M., WEI, M.X., TAMIYA, T., HURFORD, R.K., KOWALL, N.W., TEPPER, R.I., BREAKFIELD, X.O., and CHIOCCA, E.A. (1994). Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and adenovirus vectors. Hum. Gene Ther. 5, 183-191.
6. CHANG, M.W., BARR, E., SELTZER, J., JIANG, Y.Q., NABEL, G.J., NABEL, E.G., PARMACEK, M.S., and LEIDEN, J.M. (1995). Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science 267, 518-522.
7. CULVER, K.W., RAM, Z., WALBRIDGE, S., ISHII, H., OLDFIELD, E.H., and BLEASE, R.M. (1992). In vivo gene transfer with retroviral vector producer cells for treatment of experimental brain tumours. Science 256, 1550-1552.
8. SALCMAN, M. (1980). Survival in glioblastoma. Historical perspective. Neurosurgery 7, 435-439.
9. VIOLA, J.J., RAM, Z., WALBRIDGE, S., OSHIRO, E.M., TRAPNELL, B., TAO-CHEN, J.-H., and OLDFIELD, E.H. (1995). Adenovirally mediated gene transfer into experimental solid brain tumors and leptomeningeal cancer cells. J. Neurosurg. 82, 70-76.
10. YLÄ-HERTTUALA, S. (1998). Gene therapy and brain tumors. In Brain Tumor Invasion: Biological, Clinical and Therapeutic Considerations. T. Mikkelsen, R. Bjerkvig, O.D. Laerum, and M.L. Rosenblum, eds. (Wiley-Liss, New York) pp. 435-445.
11. YLÄ-HERTTUALA, S., ROSENFELD, M.E., PARTHASARATHY, S., GLASS, C.K., SIGAL, E., WITZTUM, J.L., and STEINBERG, D. (1990). Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc. Natl. Acad. Sci. U.S.A. 87, 6959-6963.
12. YLÄ-HERTTUALA, S., LUOMA, J., VIITA, H., HILTUNEN, T., SISTO, T., and NIKKARI, T. (1995). Transfer of 15-lipoxygenase gene into rabbit iliac arteries results in the appearance of oxidation-specific lipid-protein adducts characteristic of oxidized low density lipoprotein. J. Clin. Invest. 95, 2692-2698.